| Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors A Duenas-Gonzalez, M Candelaria, C Perez-Plascencia, ... Cancer treatment reviews 34 (3), 206-222, 2008 | 423 | 2008 |
| A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors M Candelaria, D Gallardo-Rincón, C Arce, L Cetina, JL Aguilar-Ponce, ... Annals of Oncology 18 (9), 1529-1538, 2007 | 296 | 2007 |
| Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance J López, A Poitevin, V Mendoza-Martínez, C Pérez-Plasencia, ... BMC cancer 12, 1-14, 2012 | 229 | 2012 |
| Crosstalk between long non-coding RNAs, micro-RNAs and mRNAs: deciphering molecular mechanisms of master regulators in cancer E López-Urrutia, LP Bustamante Montes, ... Frontiers in oncology 9, 669, 2019 | 191 | 2019 |
| Protein kinases and transcription factors activation in response to UV-radiation of skin: Implications for carcinogenesis C López-Camarillo, EA Ocampo, ML Casamichana, C Pérez-Plasencia, ... International journal of molecular sciences 13 (1), 142-172, 2011 | 183 | 2011 |
| A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer C Arce, C Pérez-Plasencia, A González-Fierro, E de la Cruz-Hernández, ... PloS one 1 (1), e98, 2006 | 171 | 2006 |
| Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study A Chavez-Blanco, B Segura-Pacheco, E Perez-Cardenas, L Taja-Chayeb, ... Molecular cancer 4, 1-9, 2005 | 170 | 2005 |
| Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines A Chavez-Blanco, C Perez-Plasencia, E Perez-Cardenas, ... Cancer cell international 6, 1-9, 2006 | 163 | 2006 |
| Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico C Villarreal‐Garza, RM Alvarez‐Gómez, C Pérez‐Plasencia, LA Herrera, ... Cancer 121 (3), 372-378, 2015 | 132 | 2015 |
| Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma. SM Hidalgo A, Baudis M, Petersen I, Arreola H, Piña P, Vázquez-Ortiz G ... BMC Cancer 5 (77), 2005 | 113 | 2005 |
| Strategies for the evaluation of DNA damage and repair mechanisms in cancer G Figueroa‑González, C Pérez‑Plasencia Oncology letters 13 (6), 3982-3988, 2017 | 110 | 2017 |
| Targeted treatments for cervical cancer: a review O Peralta-Zaragoza, VH Bermúdez-Morales, C Pérez-Plasencia, ... OncoTargets and therapy, 315-328, 2012 | 110 | 2012 |
| MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance A Pedroza-Torres, E López-Urrutia, V García-Castillo, N Jacobo-Herrera, ... Molecules 19 (5), 6263-6281, 2014 | 102 | 2014 |
| Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells O Peralta-Zaragoza, J Deas, A Meneses-Acosta, F De la O-Gómez, ... BMC cancer 16, 1-16, 2016 | 101 | 2016 |
| MetastamiRs: non-coding microRNAs driving cancer invasion and metastasis C Lopez-Camarillo, LA Marchat, E Arechaga-Ocampo, C Perez-Plasencia, ... International journal of molecular sciences 13 (2), 1347-1379, 2012 | 93 | 2012 |
| Medicinal plants used in Mexican traditional medicine for the treatment of colorectal cancer NJ Jacobo-Herrera, FE Jacobo-Herrera, A Zentella-Dehesa, ... Journal of ethnopharmacology 179, 391-402, 2016 | 90 | 2016 |
| Second hit in cervical carcinogenesis process: involvement of wnt/beta catenin pathway C Perez-Plasencia, A Duenas-Gonzalez, B Alatorre-Tavera International archives of medicine 1 (1), 10, 2008 | 89 | 2008 |
| Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial M Candelaria, A Herrera, J Labardini, A González-Fierro, C Trejo-Becerril, ... Annals of hematology 90, 379-387, 2011 | 81 | 2011 |
| Genome wide expression analysis in HPV16 cervical cancer: identification of altered metabolic pathways C Pérez-Plasencia, G Vázquez-Ortiz, R López-Romero, P Piña-Sanchez, ... Infectious agents and cancer 2, 1-10, 2007 | 79 | 2007 |
| Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade MA Fonseca-Sánchez, S Rodríguez Cuevas, G Mendoza-Hernández, ... International journal of oncology 41 (2), 670-680, 2012 | 77 | 2012 |
Alfonso Duenas-GonzalezUnit of Biomedical Research on Cancer, Instituto de Investigaciones Biomedicas UNAM, InstitutoVerified email at incan.edu.mx
